Market Place
Sourcing Support
Telomir Reports Lifespan Restoration In Progeria Preclinical Model
07 Jan 2025 //
ACCESSWIRE
Telomir Confirms Copper Binding of Telomir-1, Wilson’s Disease
23 Dec 2024 //
ACCESSWIRE
Telomir Raises $1M In Premium No-Warrant Stock Deal At $7/Share
12 Dec 2024 //
ACCESSWIRE
Telomir Reverses Type 2 Diabetes Parameters in Preclinical Study
03 Dec 2024 //
ACCESSWIRE
Telomir Pharma Confirm Age Reversal, Longevity in Preclinical Study
21 Nov 2024 //
ACCESSWIRE
Telomir Pharmaceuticals Announces Passing Of CEO Dr. Christopher Chapman
12 Aug 2024 //
GLOBENEWSWIRE
Telomir Pharmaceuticals Added To Russell 3000 And Microcap Indexes
02 Jul 2024 //
GLOBENEWSWIRE
Telomir Pharmaceuticals Scientific Advisor To Participate In DIA 2024 Panel
17 Jun 2024 //
GLOBENEWSWIRE
Telomir Hits Milestones For Telomir-1 Candidate
30 May 2024 //
GLOBENEWSWIRE
Telomir Unveils Compelling Pre-Clinical Data on Age-Reversal Drug Telomir-1
16 Apr 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.